NewMed Energy - Limited Partnership (DKDRF) Comparison with companies in other sectors?

NewMed Energy - Limited Partnership has a share price of 1.17B. You can analyze NewMed Energy - Limited Partnership (DKDRF) competitors across different market sectors through stock heatmaps.

What are DKDRF's NET and operating margins?

NewMed Energy - Limited Partnership (DKDRF) operating margin is around 0.65, and net profit margin is approximately 0.46 as of the latest reports.

In what way does DKDRF's earnings per share (EPS) trend reflect its financial momentum?

NewMed Energy - Limited Partnership (DKDRF) EPS is 0.44 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for NewMed Energy - Limited Partnership is 10.63, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for NewMed Energy - Limited Partnership?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for NewMed Energy - Limited Partnership like P/E which is 10.56, P/B which is 2.98, and PEG which is 0.11. Compare them with sector averages to evaluate if the stock is priced fairly.

NewMed Energy - Limited Partnership

DKDRF•PNK

Energy

Oil & Gas Exploration & Production

$4.68

$-0.13(-2.70%)

Fundamental Analysis of NewMed Energy - Limited Partnership (DKDRF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.44

P/E Ratio

10.63

ROE

0.30%

Net Margin

0.46%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.49B

Shares OutstandingTotal number of shares issued

$1.17B

Book Value/ShareNet worth per share

$1.57

Revenue/ShareAnnual revenue per share

$0.95

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.44

Net MarginNet income as percentage of revenue

46.50%

Operating MarginOperating income as percentage of revenue

64.63%

ROEReturn on shareholders' equity

29.65%

ROAReturn on total assets

12.80%

ROCEReturn on capital employed

20.87%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.43

Cash/ShareCash and equivalents per share

$0.37

FCF YieldFree cash flow as percentage of market cap

9.10%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.21

Dividend YieldAnnual dividend as percentage of stock price

4.56%

Financial Ratios Analysis data is not available for DKDRFFinancial Ratios Analysis details for DKDRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DKDRFSector Benchmarking details for DKDRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for NewMed Energy - Limited Partnership Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of NewMed Energy - Limited Partnership. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account NewMed Energy - Limited Partnership's unique business strengths and challenges.

Key Financial Metrics for NewMed Energy - Limited Partnership

For NewMed Energy - Limited Partnership, essential financial indicators include EPS 0.44, PE 10.63, and ROE 0.30. These key ratios reveal insights into NewMed Energy - Limited Partnership's profitability, valuation, and operational health. Understanding these metrics enables you to compare NewMed Energy - Limited Partnership with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of NewMed Energy - Limited Partnership

Metrics like Net Margin 46.50% and ROA 12.80% shed light on how well NewMed Energy - Limited Partnership is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether NewMed Energy - Limited Partnership can sustain its operations and continue growing in the future.

Valuation and Market Position of NewMed Energy - Limited Partnership

Using ratios such as P/B Ratio 2.98 and PEG Ratio 0.11, investors can assess whether NewMed Energy - Limited Partnership is appropriately valued based on its financials and growth potential. These figures, combined with NewMed Energy - Limited Partnership's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for NewMed Energy - Limited Partnership

Financial health indicators, such as Debt/Equity Ratio 0.86 and Cash Flow $0.43, provide a snapshot of NewMed Energy - Limited Partnership's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like NewMed Energy - Limited Partnership, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for NewMed Energy - Limited Partnership

Investing in NewMed Energy - Limited Partnership based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at NewMed Energy - Limited Partnership focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;